Clinical determination of 17-hydroxyprogesterone in serum by LC-MS/MS:: Comparison to Coat-A-Count™ RIA method

被引:38
作者
Etter, Michele L.
Eichhorst, Jeff
Lehotay, Denis C.
机构
[1] Saskatchewan Hlth Prov Lab, Regina, SK S4S 5W6, Canada
[2] Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 840卷 / 01期
关键词
LC-MS/MS; CAH; congenital adrenal hyperplasia; 17-hydroxy progesterone; RIA; SPE;
D O I
10.1016/j.jchromb.2006.04.038
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
17 alpha-Hydroxyprogesterone is a metabolic precursor of cortisol; elevated levels of 17 alpha-hydroxyprogesterone are indicative of congenital adrenal hyperplasia. Traditional determination by immunoassay is plagued by poor antibody specificity, resulting in significant interferences. This study explores an LC-MS/MS method for the quantitation of 170HP in serum. Deuterated 17 alpha-hydroxyprogesterone was added as internal standard, followed by solid-phase extraction, HPLC separation with a C16-amide reverse-phase column with run time of 7 min, and quantification by MS/MS (positive electrospray ionisation) in the selected reaction monitoring mode (SRM). Transitions monitored were 331 > 109 for the analyte and 339 > 113 for the deuterated internal standard. Intra-assay precision (%R.S.D.) was 7.4% at 7 nmol/L, inter-assay precision (%R.S.D.) at 2, 7 and 27nmol/L was 15.4, 10.0 and 7.9% and accuracy at 0.9 nmol/L was 100%. The method was linear from 0.156 to 80 nmol/L. Lower limit of quantitation was 0.2 nmol/L, providing meaningful data for patients within normal range as well as those with elevated levels. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 20 条
[1]   Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels [J].
Allen, DB ;
Hoffman, GL ;
Fitzpatrick, P ;
Laessig, R ;
Maby, S ;
Slyper, A .
JOURNAL OF PEDIATRICS, 1997, 130 (01) :128-133
[2]   A practical approach to the diagnosis of polycystic ovary syndrome [J].
Chang, RJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (03) :713-717
[3]  
*DIAGN PROD CORP, 2004, CON6 MULT CONTR MOD
[4]  
*DIAGN PROD CORP, 2003, COAT A COUNT 17A OH
[5]  
Guo TD, 2004, ARCH PATHOL LAB MED, V128, P469
[6]   Ketosteroid profiling using Girard T derivatives and electrospray ionization tandem mass spectrometry: direct plasma analysis of androstenedione, 17-hydroxyprogesterone and cortisol [J].
Johnson, DW .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (02) :193-200
[7]  
Kao PC, 2001, ANN CLIN LAB SCI, V31, P199
[8]   Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry [J].
Lacey, JM ;
Minutti, CZ ;
Magera, MJ ;
Tauscher, AL ;
Casetta, B ;
McCann, M ;
Lymp, J ;
Hahn, SH ;
Rinaldo, P ;
Matern, D .
CLINICAL CHEMISTRY, 2004, 50 (03) :621-625
[9]   Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots [J].
Lai, CC ;
Tsai, CH ;
Tsai, FJ ;
Lee, CC ;
Lin, WD .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (22) :2145-2151
[10]   Rapid screening assay of congenital adrenal hyperplasia by measuring 17α-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots [J].
Lai, CC ;
Tsai, CH ;
Tsai, FJ ;
Wu, JY ;
Lin, WD ;
Lee, CC .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2002, 16 (01) :20-25